DeSci Unites Reversing and Slowing of Aging
This online event is the kickstart of the launching week on Pump.Science where three pioneering tokens will be introduced by Rapamycin Longevity Lab and Reprogramming Lab. We will begin the event by a live launch of a chemical partial reprogramming token. A longevity intervention focused on reversing cellular age.
Later in the week the vision expands as we launch a token on Wednesday that combines chemical partial reprogramming with the mTOR inhibitor Rapamycin, the gold standard compound for slowing down aging across multiple species. Friday marks the grand finale where chemical partial reprogramming is combined with Omipalisib, a dual PI3K/mTOR inhibitor with a potential to exceed the longevity effects of Rapamycin.
All this is made possible through the pioneering Decentralized Science (DeSci) platform Pump.Science, a fast‑growing platform that opens the door to new funding models, accelerated discovery and new ways of driving longevity breakthroughs forward. Through Pump.Science we are now uniting reversal and slowing of aging with the purpose to explore and push the boundaries of human longevity.
Agenda
Live launch of the first token on Pump.Science
Pump.Science presentation
The Potential of DeSci and Longevity
What are partial reprogramming and mTOR and why combine them?
Longevity Biotech Fellowship and the mission to solve aging
Closing remarks and next step
Launch schedule on Pump.Science
Nov 10th: Chemical partial reprogramming
Nov 12th: Chemical partial reprogramming + Rapamycin
Nov 14th: Chemical partial reprogramming + Omipalisib